FedEx(US:FDX) Zhong Guo Min Hang Wang·2025-07-02 08:53Core Viewpoint - FedEx has received the "Pharmaceutical Logistics Independent Validation Excellence Center" certification from IATA for its Asia-Pacific hub at Guangzhou Baiyun International Airport, marking it as the first global logistics company to achieve this certification in both air hub and ground operations [1] Company Summary - FedEx's certification ensures the highest standards in handling and transporting temperature-sensitive healthcare products, such as pharmaceuticals and vaccines, within its air logistics network [1] - The President of FedEx China, Xu Baoyan, emphasized the growing demand for professional logistics services in China's healthcare sector, highlighting the company's unique advantages in providing one-stop global delivery services and intelligent digital solutions [1] - FedEx's data indicates that the Chinese pharmaceutical logistics market is expected to experience significant growth, with a projected compound annual growth rate (CAGR) of 10% to 12% from 2025 to 2030 [1] Industry Summary - In the healthcare and pharmaceutical sectors, air logistics customers require closed-loop temperature control services to ensure product stability and efficacy [1] - FedEx leverages decades of expertise, a robust global transportation network, and customized time-sensitive delivery services to provide tailored solutions for clinical trials, biopharmaceuticals, and vaccine transportation [1] - FedEx operates global life sciences centers located in Incheon (South Korea), Singapore, Tokyo (Japan), Mumbai (India), Memphis (USA), and Veldhoven (Netherlands), with 19 core facilities worldwide adhering to the quality framework of the Pharmaceutical Logistics Independent Validation Excellence Center by May 2025 [1]